Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Tumor-Agnostic 1Sarcoma 1Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Specimen Handling 80Fluorouracil 76Oxaliplatin 70Magnetic Resonance Spectroscopy 61Leucovorin 60Gemcitabine 56Bevacizumab 56Biopsy 41Capecitabine 40Irinotecan 38Cisplatin 37pembrolizumab 35Nivolumab 35Cetuximab 33durvalumab 30130-nm albumin-bound paclitaxel 29Paclitaxel 27atezolizumab 21Folfox protocol 20Radiotherapy 17Carboplatin 17Taxes 16dehydroftorafur 15Cyclophosphamide 15Radiation 14fludarabine 13X-Rays 13Surgical Procedures, Operative 13Albumin-Bound Paclitaxel 13trastuzumab deruxtecan 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tiragolumab × Gastrointestinal × 30 days × Clear all
NCT04929223 2026-05-26

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

Hoffmann-La Roche

Phase 1 Recruiting
542 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡